Home>Topics>Stocks>Roche Holding AG ADR

Roche Holding AG ADR RHHBY

  1. All
  2. Commentary
  3. Headlines
    1. A Push-Me, Pull-You Market


      Thu, 16 Apr 2015

      Maxygen MAXY announced that its partner Roche RHHBY placed a hold on development of Maxy-Alpha--the first of Maxygen's shuffled proteins to enter clinical development--and

    2. "too much" price appreciation?


      Wed, 8 Apr 2015

      173% since I purchased it in 2008, now yielding 2.34% LLY, up 113% since I purchased it in 2011, now yielding 2.77% RHHBY , up 103% since I purchased it in 2010, now yielding 3.15% All of these were yielding over 5% when I bought them. I also

    3. Actavis' Wide-Moat Transformation Offers Shareholder Rewards


      Mon, 23 Mar 2015

      injection frequency, a considerable improvement over current anti-VEGF treatments that require monthly injections (Roche's RHHBY Lucentis) and bimonthly injections (Regeneron's REGN Eylea). We think the first DARPin molecule is likely to enter Phase

    4. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks


      Tue, 17 Mar 2015

      yielding stocks of our Ultimate Stock-Pickers since we last looked at them , with Vodafone Group VOD, Pfizer PFE, Roche RHHBY , and Eli Lilly LLY making way for Occidental Petroleum, National Oilwell Varco, Emerson Electric EMR , and Exxon Mobil

    5. Complexities of Eye Care Drive Strong Moats


      Fri, 6 Mar 2015

      degeneration have been wildly successful, with Regeneron 's REGN and Bayer 's BAYRY Eylea and Novartis ' NVS and Roche 's RHHBY Lucentis both easily reaching blockbuster status. Other eye-care pharmaceuticals include treatments for glaucoma, dry eye

    6. From Barron’s, January 19, 2015 (Part 2)


      Sat, 17 Jan 2015

      beaten down telecom providers [ CIEN, HRS,ARRS. RKUS, ALU, ERIC, NOK ; pg 28]; healthcare [ BIIB, BMRN, BMY, RHHBY , GILD, Spark Therapeutics (upcoming IPO), AGTC, BLUE ; pg 34]; SK Telecom [ SKM ; pg 34]. PSX story http://online

    7. Leader in Genomic Sequencing Illuminates the Way


      Wed, 14 Jan 2015

      benefit from this increased spending on sequencing. Second, we think Illumina will continue to gain market share from Roche RHHBY and Thermo Fisher TMO , enabling the company to grow faster than the cumulative sequencing market. Third, Illumina’s ongoing product

    8. Nominees for 2014 International-Stock Manager of the Year


      Tue, 6 Jan 2015

      soared more than 60% in 2014. The fund also benefited from well-known, fairly steady firms such as Novartis NVS and Roche RHHBY , top-five holdings that posted double-digit gains in a tough year. Yet as the ICICI Bank play shows, the managers have

    9. Ultimate Stock-Pickers: Top Holdings of Top-Performing Managers


      Tue, 16 Dec 2014

      4 FedEx FDX 2 Narrow 175.79 1.11 Medium 49,485 4.3 Microsoft MSFT 3 Wide 46.95 1.02 Medium 385,197 4.3 Roche RHHBY 2 Wide 36.86 1.05 Low 245,573 4.1 Texas Inst TXN 2 Wide 53.11 1.13 Medium 54,684 3.9 Adobe ADBE 2 Wide 76

    10. A Preview of the 2014 Morningstar International-Stock Fund Manager of the Year Competition


      Tue, 4 Nov 2014

      returns. And the team, which received the honors in 2000 and 2011, has been firing on all cylinders this year. Roche Holding RHHBY and Zurich Insurance ZURVY of Switzerland have posted solid gains, as have some of the team's other health-care and financial

    « Prev12345Next »
    Content Partners